Grace Therapeutics (GRCE) vs Nasus Pharma (NSRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Grace Therapeutics (GRCE) has outperformed Nasus Pharma (NSRX) over the past year, losing 30.5% versus a loss of 47.6%. Grace Therapeutics is the larger company by market cap ($42.9 million vs $42.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRCE | NSRX |
|---|---|---|
| Share price | $2.04 | $3.63 |
| Market cap | $42.91M | $42.52M |
| 1-day change | -2.86% | -3.84% |
| YTD return | -39.31% | -58.74% |
| 1-year return | -30.46% | -47.64% |
| 5-year return | -79.89% | — |
| EPS (TTM) | $-1.17 | $-1.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.18 | $9.50 |
| 52-week low | $1.79 | $1.98 |
| Distance from 52-week high | -60.62% | -61.79% |
| Average volume | 171.87K | 16.09K |
| Shares outstanding | 21.04M | 11.71M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRCE has outperformed NSRX by 17.2 percentage points over the past year.
GRCE vs NSRX FAQ
Which is bigger, Grace Therapeutics or Nasus Pharma?
Grace Therapeutics (GRCE) is larger, with a market capitalization of $42.91M compared with $42.52M for Nasus Pharma (NSRX).
Which stock has performed better over the past year, GRCE or NSRX?
GRCE returned -30.46% over the past 12 months, compared with -47.64% for NSRX (price return, excluding dividends). Past performance does not predict future results.
Are Grace Therapeutics and Nasus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.